762 related articles for article (PubMed ID: 21586936)
41. (18)F-FDG PET/CT of adrenal lesions.
Dong A; Cui Y; Wang Y; Zuo C; Bai Y
AJR Am J Roentgenol; 2014 Aug; 203(2):245-52. PubMed ID: 25055255
[TBL] [Abstract][Full Text] [Related]
42. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
[TBL] [Abstract][Full Text] [Related]
43. Prone position PET/CT is useful in reducing gravity-dependent opacity-related [
Song YH; Moon JW; Kim YN; Woo JY; Son HJ; Lee SH
Eur Radiol; 2023 Nov; 33(11):8270-8278. PubMed ID: 37322163
[TBL] [Abstract][Full Text] [Related]
44. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
45. ¹⁸F-FDG-PET/CT in malignant mesothelioma.
Fuccio C; Spinapolice EG; Ferretti A; Castellucci P; Marzola MC; Trifirò G; Rubello D
Biomed Pharmacother; 2013 Jul; 67(6):539-42. PubMed ID: 23583476
[TBL] [Abstract][Full Text] [Related]
46. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
47. The role of
McDonald EO; Amanullah AA; Park PSU; Song W; Werner TJ; Alavi A; Revheim ME
Ann Nucl Med; 2023 Jun; 37(6):328-348. PubMed ID: 37095393
[TBL] [Abstract][Full Text] [Related]
48. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.
Lei W; Zeng H; Zeng DX; Zhang B; Zhu YH; Jiang JH; Huang JA
Br J Radiol; 2016; 89(1057):20150695. PubMed ID: 26529231
[TBL] [Abstract][Full Text] [Related]
49. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
50. Higher fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) uptake in tuberculous compared to bacterial spondylodiscitis.
Bassetti M; Merelli M; Di Gregorio F; Della Siega P; Screm M; Scarparo C; Righi E
Skeletal Radiol; 2017 Jun; 46(6):777-783. PubMed ID: 28299432
[TBL] [Abstract][Full Text] [Related]
51. Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism.
Lee EJ; Moon SH; Choi JY; Lee KS; Choi YS; Choe YS; Lee KH; Kim BT
ANZ J Surg; 2013 May; 83(5):342-7. PubMed ID: 22943630
[TBL] [Abstract][Full Text] [Related]
52. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
Vali R; Punnett A; Bajno L; Moineddin R; Shammas A
Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
[TBL] [Abstract][Full Text] [Related]
53. (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response.
Martinez V; Castilla-Lievre MA; Guillet-Caruba C; Grenier G; Fior R; Desarnaud S; Doucet-Populaire F; Boué F
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1180-5. PubMed ID: 22794271
[TBL] [Abstract][Full Text] [Related]
54. [Usefulness of (18)FDG PET-CT scan as a diagnostic tool of fever of unknown origin].
García-Gómez FJ; Acevedo-Báñez I; Martínez-Castillo R; García-Gutiérrez M; Tirado-Hospital JL; Borrego-Dorado I
Med Clin (Barc); 2015 Jul; 145(2):62-6. PubMed ID: 25500351
[TBL] [Abstract][Full Text] [Related]
55. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
56. Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.
El-Bawab H; Al-Sugair AA; Rafay M; Hajjar W; Mahdy M; Al-Kattan K
Eur J Cardiothorac Surg; 2007 Apr; 31(4):731-6. PubMed ID: 17293120
[TBL] [Abstract][Full Text] [Related]
57. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
[TBL] [Abstract][Full Text] [Related]
58. Present and future of PET and PET/CT in gynaecologic malignancies.
Musto A; Rampin L; Nanni C; Marzola MC; Fanti S; Rubello D
Eur J Radiol; 2011 Apr; 78(1):12-20. PubMed ID: 20116952
[TBL] [Abstract][Full Text] [Related]
59. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis.
Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR
J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986
[TBL] [Abstract][Full Text] [Related]
60. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study.
Sperti C; Pasquali C; Decet G; Chierichetti F; Liessi G; Pedrazzoli S
J Gastrointest Surg; 2005 Jan; 9(1):22-8; discussion 28-9. PubMed ID: 15623441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]